Highly coordinated nationwide massive travel restrictions are central to effective mitigation and control of Covid-19 outbreaks in China Proc. R. Soc. A, 478 (2260) (2022), Article 20220040 Google Scholar [84] Hiroshi Nishiura, Natalie M. Limton, Andrei R. Akhmetzhanov Serial interval of no...
Article 23 December 2022 Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 Article 31 July 2020 COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study Arti...
In order to strengthen the rehabilitation and health management of the hospital discharged COVID-19 patients, CM has been used as a treatment in China during the outbreak. Some of the early papers reported that over 85% of COVID-19 infected patients in China were receiving CM treatment, with...
Arranz, Beatriz Dietl, Alex Serra-Llovich, Pere Soler, Roger Colobrán, Andrea Martín-Nalda, Alba Parra Martínez, David Bernardo, Silvia Rojo, Aida Fiz-López, Elisa Arribas, Paloma de la Cal-Sabater, Tomás Segura, Esther González-Villa, Gemma Serrano-Heras, Joan Martí-Fàbregas, Elena...
Simbana-Rivera K, Gomez-Barreno L, Guerrero J, Simbana-Guaycha F, Fernandez R, Lopez-Cortes A, et al. Interim analysis of pandemic Coronavirus disease 2019 (COVID-19) and the SARS-CoV-2 virus in Latin America and the Caribbean: morbidity, mortality and molecular testing trends in the ...
Critical Care 2022 26:308 Perspective Published on: 8 October 2022 Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, et al. Critical...
2017; Siami-Namini et al. 2018; Minami, 2018; Fischer and Krauss, 2018; Ji et al. 2019; Livieris et al. 2020). The aim of this paper is to design Long Short-Term Memory (LSTM) neural network to predict financial time series under COVID-19 pandemic crisis period. Our LSTM ...
In December 2019, a new coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and associated disease, coronavirus disease 2019 (COVID-19), was identified in China. This virus spread quickly and in March, 2020, it was declared a pandem
https://doi.org/10.1016/j.jacep.2020.08.002Get rights and content Under an Elsevier user license open archiveHighlights Abstract Current understanding of the impact of coronavirus disease-2019 (COVID-19) on arrhythmias continues to evolve as new data emerge. Cardiac arrhythmias are more common in...
An anti-influenza NA mAb (Flu mAb), used as a negative control, showed no binding to RBD-SpyVLP, confirming the specificity of the assay (Fig. 2a). Fig. 2: RBD-SpyVLPs are reactive to SARS-CoV-2 specific monoclonal antibodies and ACE2-Fc, and are thermostable and resilient. a ...